Cellbricks


Cellbricks Therapeutics is a biotech company pioneering regenerative medicine and longevity through deeptech innovation. It develops scalable, implantable tissue grafts using proprietary biofabrication technology, advanced biomaterials, and human cells to restore tissue and organ function. The company aims to transform healthcare by providing reliable, scalable, and immune-compatible tissue therapeutics.

Industries

3d-printing
biotechnology
life-science
manufacturing

Nr. of Employees

small (1-50)

Cellbricks

Berlin, Berlin, Germany, Europe


Products

Preclinical soft tissue therapeutic (adipose graft)

Biofabricated adipose tissue grafts designed to fill and heal deep complex wounds; in vivo preclinical data show host integration, rapid vascularization and absence of fibrosis in mouse models.

Preclinical liver tissue therapeutic

Biofabricated metabolically active liver tissue designed to restore liver function and potentially act as a bridge to transplantation; demonstrated sustained metabolic activity in preclinical studies.


Services

Preclinical development and translational research partnerships

Collaborative program development and execution of preclinical studies, technology validation and translational planning with academic and clinical partners.

Expertise Areas

  • Light-based biofabrication
  • 3D bioprinting and tissue engineering
  • Biomaterials and bioink formulation
  • Vascularized tissue engineering
  • Show More (6)

Key Technologies

  • Light-based projection photopolymerization
  • AI-driven tissue design and process control
  • Tailor-made bioinks/hydrogel formulations
  • Image recognition for inline quality control
  • Show More (3)

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.